Revisiting racial disparities in access to surgical management of drug-resistant temporal lobe epilepsy post implementation of Affordable Care Act

- Affordable Care Act(ACA) has provided healthcare access to 7-16 million uninsured Americans.
- Studies demonstrated racial disparity in access to epilepsy surgery pre ACA amendment.
- We investigated racial disparity, if at all, in access to epilepsy surgery post ACA.
- We test our hypothesis using data from the National Inpatient Sample (2012-2013).

ObjectivesPrior to enactment of the Affordable Care Act(ACA), several reports demonstrated remarkable racial disparities in access to surgical care for epileptic patients. Implementation of ACA provided healthcare access to 7-16 million uninsured Americans. The current study investigates racial disparity post ACA era in (1) access to surgical management of drug-resistant temporal lobe epilepsy (DRTLE); (2) short-term outcomes in the surgical cohort.Patient and methodsAdult patients with DRTLE registered in the National Inpatient Sample (2012-2013) were identified. Association of race (African Americans and other minorities with respect to Caucasians) with access to surgical management of TLE, and short-term outcomes [discharge disposition, length of stay (LOS) and hospital charges] in the surgical cohort were investigated using multivariable regression techniques.ResultsOf the 4062 patients with DRTLE, 3.6%(n = 148) underwent lobectomy. Overall, the mean age of the cohort was 42.35 ± 16.33 years, and 54% were female. Regression models adjusted for patient demographics, clinical and hospital characteristics demonstrated no racial disparities in access to surgical care for DRTLE. Likewise, no racial disparity was noted in outcomes in the surgical cohort.ConclusionOur study reflects no racial disparity in access to surgical care in patients with DRTLE post 2010 amendment of the ACA. The seismic changes to the US healthcare system may plausibly have accounted for addressing the gap in racial disparity for epilepsy surgery.